CAS 1655504-04-3

Orelabrutinib

CAS: 1655504-04-3

Orelabrutinib (ICP-022) is an orally active and irreversible inhibitor of Bruton's tyrosine kinase (BTK).

Formel: C₂₆H₂₅N₃O₃

Reinheit: 97.77% - 99.54%

Farbe und Form: Solid

Molekulargewicht: 427.49

Ref: TM-T12317

6-(1-Acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide

CAS: 1655504-04-3

Formel: C₂₆H₂₅N₃O₃

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 427.4950

Ref: IN-DA01KFHU

6-(1-Acryloylpiperidin-4-Yl)-2-(4-Phenoxyphenyl)Nicotinamide

CAS: 1655504-04-3

6-(1-Acryloylpiperidin-4-Yl)-2-(4-Phenoxyphenyl)Nicotinamide

Reinheit: 98%

Molekulargewicht: 427.5g/mol

Ref: 54-OR1023016

Orelabrutinib

CAS: 1655504-04-3

Orelabrutinib

Reinheit: ≥95%

Molekulargewicht: 427.49g/mol

Ref: 54-BUP12496

Orelabrutinib

CAS: 1655504-04-3

Orelabrutinib is a small-molecule Bruton’s tyrosine kinase (BTK) inhibitor, which is synthesized chemically. This selective inhibitor targets BTK, a key enzyme involved in the B-cell receptor signaling pathway. By binding covalently to cysteine-481 in BTK, orelabrutinib effectively blocks the downstream signaling, leading to apoptosis of malignant B-cells.

Formel: C₂₆H₂₅N₃O₃

Reinheit: Min. 95%

Molekulargewicht: 427.5 g/mol

Ref: 3D-FRC50404

6-(1-Acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide

CAS: 1655504-04-3

Reinheit: 98%

Molekulargewicht: 427.5039978

Ref: 10-F549430